ERBB2 and breast cancer: • Lapatinib treatment of sensitive, but not resistant, HER2+ breast cancer cells led to increased Bim expression.• Downregulation of PTK6 induced apoptosis of resistant breast cancer cells through a Bim-dependent mechanism.